Ticker name:ROIV Roivant Sciences Ltd.
Country: GB-Sector: Healthcare, Industry: Biotechnology
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
- CEO: Matthew Gline
- IPO: Dec 08, 2020
- Website:roivant.com (open a new tab)
Market Cap 23B
Last close 32.41$
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 109B | 430.44$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 68B | 649.76$ | |
| 3 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 40B | 298.48$ | |
| 4 | RVMD | Revolution Medicines, Inc. | 32B | 150.33$ | |
| 5 | RPRX | Royalty Pharma plc | 31B | 53.06$ | |
| 6 | UTHR | UNITED THERAPEUTICS Corp | 24B | 563.93$ | |
| 7 | INSM | INSMED Inc | 23B | 107.91$ | |
| 8 | ROIV | Roivant Sciences Ltd. | 23B | 32.41$ | |
| 9 | INCY | INCYTE CORP | 19B | 97.08$ | |
| 10 | MRNA | Moderna, Inc. | 19B | 48.12$ | |
| 11 | GMAB | GENMAB A/S | 17B | 27.21$ | |
| 12 | JAZZ | Jazz Pharmaceuticals plc | 15B | 239.01$ | |
| 13 | ASND | Ascendis Pharma A/S | 15B | 241.34$ | |
| 14 | SMMT | Summit Therapeutics Inc. | 14B | 17.89$ | |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13B | 68.22$ | |
| 16 | EXEL | EXELIXIS, INC. | 13B | 49.9$ | |
| 17 | IONS | IONIS PHARMACEUTICALS INC | 12B | 75.06$ | |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12B | 230.62$ | |
| 19 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 12B | 513.47$ | |
| 20 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 11B | 77.14$ |